Scott Batey, PhD, MSW

Professor

He/Him

Room 404, 127 Elk Place, Mail Code 8906
Scott Batey

Biography

Dr. D. Scott Batey is a Professor in the School of Social Work at Tulane University. Prior to his transition to Tulane, Dr. Batey served as faculty of the Department of Social Work, College of Arts and Sciences, at the University of Alabama at Birmingham (UAB) where he directed the Honors Program. He maintains an affiliation as Scientist with the UAB Center for AIDS Research (CFAR), where he led the Center’s community engagement efforts as the Engagement and Continuum of Care Specialist for five years. In general, Dr. Batey’s research focuses on eliminating health disparities, especially those prominent along the HIV Care Continuum. Within this framework, he conducts mixed-methods research to improve HIV health outcomes among people living with or at risk for acquiring HIV. Informed by 26 years’ experience as a licensed social work clinician, his implementation research especially leverages the inherent skills of social workers to uniquely deliver evidence-based interventions; it is routinely community-placed and community-driven. His major scientific contributions center on implementation of promising interventions and delivery strategies that effectively and efficiently address gaps in the HIV Care Continuum, utilize evidence-based social work practice, reduce health-related stigmas, and optimize the primary medical clinic-community interface.

Dr. Batey is currently the Multiple Principal Investigator on three National Institutes of Health R01 studies through the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Nursing Research (NINR), and the National Institute of Mental Health (NIMH). In this research portfolio, Dr. Batey and his colleagues at the University of Alabama at Birmingham collaborate with health departments in Alabama, Louisiana, and Mississippi to use big (HIV surveillance) data to understand temporal and geographic differences in time from HIV diagnosis to viral suppression (R01AI142690, MPI, A.I. Rana & D.S. Batey). In partnership with colleagues at Columbia University, Dr. Batey is testing the efficacy of a combination community health worker and mobile health (mHealth) app to improve antiretroviral adherence and viral suppression among persons with HIV in New York City and Birmingham, AL (R01NR019758, MPI: R. Schnall & D.S. Batey). Through his collaboration with colleagues at the University of Chicago, Dr. Batey and his team are conducting a Hybrid Type I effectiveness-implementation trial of the evidence-based HIV retention in care intervention, Project nGage, in Chicago and Birmingham (R01MH125744, MPI: A. Bouris & D.S. Batey).

Dr. Batey serves as the Co-Director of the Birmingham AIDS Outreach Magic City Research Institute (HIV research | Magic City Research Institute | United States). He is an author on 60 peer-reviewed publications and over 150 oral and poster abstracts that have been presented regionally, nationally, and internationally. Dr. Batey has been a mentor for countless students, community stakeholders, and junior faculty members of various disciplines.

Areas of Expertise

  • Clinical Social Work
  • Community Organizing and Advocacy
  • Medical Social Work
  • Program Development and Evaluation
  • Research
  • Social Determinants of Health

Education

  • PhD from the University of Alabama
  • MSW from the University of Alabama
  • BS from the University of Alabama

Selected Publications

  • Johnson, KA, Bui, C, Graham, HK, Mayfield, C, Payne-Foster, P, Albright, DL, & Batey, DS. The role of peer patient navigation in enhancing PrEP persistence among LGBTQ+ populations and other individuals at high susceptibility to HIV transmission in the Deep South state of Alabama. In press, AIDS and Behavior.
  • Forster, R, Schnure, M, Jones, J, Lesko, C, Batey, DS, Butler, I, Ward, D, Musgrove, K, Althoff, KN, Jain, M, Gebo, K, Dowdy, DW, Shah, M, Kasaie, P, & Fojo, AT. The potential impact of ending the Ryan White HIV/AIDS program in HIV incidence: A simulation study in 31 cities. In press, Ann Intern Med.
  • Hahn, AW, Ruderman, SA, Nance, RM, Whitney, BM, Eltonsy, S, Haidar, L, Drumright, LN, Ma, J Mayer, KH, Napravnik, S, Eron, JJ, Christopoulos, KA, Bamfod, L, Cachay, E, Yendewa, G, Pettit, A, Saag, MS, Heath, SL, Moore, RD, Keruly, J, Batey, DS, Chander, G, Kitahata, MM, Delaney, JAC, & Fredericksen, RJ. Racial inequity in prescription of semaglutide among eligible people with HIV. In press, Diabetes Care.
  • Klitzman, R, Gamble, T, Dormitzer, J, Root, C, Lowensen, K, Batey, DS, Remien, RH, Beyrer, C, and the HPTN 078 Study Team. Ethics of parental consent in HIV Prevention research using adolescents: The case of HPTN 078. In press, J Homosexuality.
  • Crane, HM, Dai, M, Fredericksen, R, Drumright, L, Mayer, KH, Fleming, JG, Cachay, ER, Bamford, L, Christopoulos, K, Botero, V, Safren, SA, Rodriquez, AE, Yendewa, G, Willis, B, Han, K, LeBlanc, S, Moore, RD, Keruly, JC, Chander, G, Napravnik, S, Webel, A, Willig, AL, Batey, DS, Burkholder, G, Heath, SL, McReynolds, J, Mixson, S, Whitney, BM, Nance, RM, Saag, MS, Kitahate, MM, Delaney, JAC, & Lober, WB. Routine collection of patient-reported outcomes in HIV clinics: Lessons learned after more than 130,000 assessments have been completed. In press, AIDS.
  • Van Gerwen, OT, Day, KS, Aaron, KJ, Lindl, H, Miller, GH, Batey, DS, Siwakoti, K, Wall, J, Patterson, B, Turan, B, & Muzny, CA. From trauma to trust: The development of a survey instrument measuring trauma among transgender women in the US Deep South. Front Public Health. 2025 Sept 3. doi: 10.3389/fpubh.2025.1632285.
  • Hai, AH, Schnall, R, & Batey, DS. Differential effects of substance use on HIV outcomes: A longitudinal analysis among people with HIV. AIDS Patient Care STDS. 2025 Aug 8. doi: 10.1177/10872914251364664. Online ahead of print. PMID: 40780810.
  • Brin, M, Kay, ES, Radix, A, Belkind, U, Batey, DS, Ferrara, S, Tanner, M, Galindo, C, Fontalvo, S, Kenniff, J, & Schnall, R. Use of cognitive interviews to develop PrEP education for men in New York and Alabama. Patient Educ Couns. 2025 Jun 6. doi: 10.1016/j.pec.2025.109221. PMID: 40554090.
  • Brin, M, Michaels, C, Veihman, P, Wood, OR, Abua, J, Kay, ES, Batey, DS, & Schnall, R. Acceptability and perceived usefulness of CHAMPS intervention for improving medication adherence among PWH in Alabama and New York. Int J Med Inform. 2025 Sep:201:105959. doi: 10.1016/j.imedinf.2025.105959. Epub 2025 May 5. PMID: 40347603.
  • Kay, ES, Shorya, S, Brin, M, Batey, DS, Radix, A, Belkind, U, Tanner, M, Galindo, C, Ferrara, S, Ott, C, & Schnall, R. Pre-exposure prophylaxis providers in Birmingham, Alabama, and New York City, New York, identify critical barriers to newer pre-exposure prophylaxis strategies: A mixed methods study. J Assoc Nurses AIDS Care. 2025 May-Jun; 36(3): 284-296. doi: 10.1097/JNC.0000000000000532. Epub 2025 Apr 4. PMID: 40272038.
  • Dos Santos, F, Batey, DS, & Schnall, R. Evaluating the usability of a mobile health technology to enhance medication adherence in people with HIV. Stud Health Technol Inform. May 15:327:1007-1008. doi: 10.3233/SHTI250529. PMID: 40380636.
  • Hai, A, Batey, DS, Lee, C, & Schnall, R. Substance use patterns among U.S. adults with HIV: Identifying priorities for screening and interventions. AIDS Care. 2025 May; 37(5):843-854. doi: 10.1080/09540121.2025.2477718. Epub 2025 Mar 17. PMID: 40094481.

Selected Funding

  • 2024, Co-Investigator/Co-Mentor, Assessing and Promoting Vaginal Health for Transgender Men: A Mixed Methods Study ($252,750), NCATS/UAB Center for Clinical and Translational Science
  • 2024-2029, Co-Investigator/Co-Mentor, Assessing and Promoting Vaginal Health for Transgender Men on Testosterone: A Mixed Methods Study ($791,124), NIH/NIAD
  • 2023-2028, Multiple Principal Investigator, Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South ($1,160,456), NIMHD 2023-2028, Multiple Principal Investigator, Drive to Zero: Developing a Digital Cohort to Understand the Drivers of Non-Sustained Viral Suppression in the Deep South ($6,212,517), NIAID
  • 2023-2028, Tulane Site PI/Co-Investigator, Understanding Health Inequities at the Intersection of the HIV and Substance Use Epidemics Across Racial/Ethnic and Other Underserved Populations ($1,035,645), NIDA
  • 2023-2028, Tulane Site PI/Co-Investigator, HIV and Substance Use Cohort Coordinating Center for Emerging and High Impact Scientific Cross Cohort Studies: HIV SUCCESS ($4,993,590), NIDA
  • 2022-2027, Tulane Site PI/Co-Investigator, Ending the HIV Epidemic in Rural America (EHE-RA): Local Interventions, Co-Epidemics, and Social Determinants ($826,191), NIH/NIMH
  • 2022-2027, Evaluator, Ending the HIV Epidemic: Addressing HIV Health and Homelessness (AH3) ($1,357,540), UAB 1917 Clinic/CFAR/ Ending HIV in Alabama Community Funding
  • 2021-2026, Tulane Site PI/Co-Investigator, mChoice: Improving the PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Flexible Retention Assistance in Two High Priority Settings ($5,191,117), CDC
  • 2021-2026, Co-Investigator, Alcohol Research Consortium in HIV: Ending the HIV Epidemic through Interventions and Epidemiology at the Intersection of the Alcohol and HIV Care Continua ($7,751,623), NIH/NIAAA
  • 2020-2025, Multiple Principal Investigator, Harnessing the Power of Social Network Support to Improve Retention in Care and Viral Suppression among Young Black Men in Chicago and Alabama: A Hybrid Type I Effectiveness-Implementation Trial of Project nGage ($2,980,183), NIH/NIMH
  • 2020-2024 (NCE 2025), Multiple Principal Investigator, CHAMPS: A Randomized Trial of a Community Health Worker Intervention for Persons Living with HIV in Two High Priority Settings ($2,877,282), NIH/NINR

Community Involvement

  • Chair, New Orleans Regional AIDS Planning Council (NORAPC)
  • Scientist, UAB Center for AIDS Research (CFAR)
  • Co-Director, Birmingham AIDS Outreach Magic City Research Institute